1. The Cost Effectiveness of Stockpiling Drugs, Vaccines and Other Health Resources for Pandemic Preparedness

   • Pedro Plans-Rubió

   Editorial Open access 04 July 2020 Pages: 393 - 395

2. Economic Evaluations of Pharmacological Treatments in Heart Failure Patients: A Methodological Review with a Focus on Key Model Drivers

   • Gian Luca Di Tanna
   • Shuxian Chen
   • Gary Globe

   Review Article Open access 26 August 2019 Pages: 397 - 401

   

3. Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review

   • Peter Wigfield
   • Urbano Sbarigia
   • Bart Heeg

   Systematic Review Open access 19 August 2019 Pages: 403 - 418

4. Benefit–Cost Analysis of the Danish Sun Safety Campaign 2007–2015: Cost Savings from Sunburn and Sunbed Use Reduction and Derived Skin Cancer Reductions 2007–2040 in the Danish Population

   • Brian Køster
   • Maria K. H. Meyer
   • Peter Dalum

   Original Research Article Open access 15 October 2019 Pages: 419 - 425

   

5. Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT

   • William Hollingworth
   • Christopher G. Fawsitt
   • the PANDA Team

   Original Research Article Open access 27 November 2019 Pages: 427 - 438

   

6. A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource Use

   • Sreevalsa Appukkuttan
   • Krishna Tangirala
   • Neal Shore

   Original Research Article Open access 22 October 2019 Pages: 439 - 447

   

7. Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium

   • C. Rinciog
   • A. Diamantopoulos
   • S. Soulard

   Original Research Article Open access 14 January 2020 Pages: 449 - 458

   

8. DyeVert™ PLUS EZ System for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Diagnostic Coronary Angiography and/or Percutaneous Coronary Intervention: A UK-Based Cost–Utility Analysis

   • Mehdi Javanbakht
   • Mohsen Rezaei Hemami
   • Stephen Wheatcroft

   Original Research Article Open access 27 January 2020 Pages: 459 - 472

   

9. Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma

   • Robert M. Rifkin
   • Jill A. Bell
   • Dorothy Romanus

   Original Research Article Open access 11 October 2019 Pages: 473 - 483

   

10. Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention

    • Itziar Oyagüez
    • Carmen Suárez
    • Javier Soto

    Original Research Article Open access 31 October 2019 Pages: 485 - 497

    

11. Cost Effectiveness of Antenatal Lifestyle Interventions for Preventing Gestational Diabetes and Hypertensive Disease in Pregnancy

    • Cate Bailey
    • Helen Skouteris
    • Zanfina Ademi

    Original Research Article Open access 05 February 2020 Pages: 499 - 510

    

12. Self-Monitoring and Management of Blood Pressure in Patients with Stroke or TIA: An Economic Evaluation of TEST-BP, A Randomised Controlled Trial

    • Lois G. Kim
    • Edward C. F. Wilson
    • John F. Potter

    Original Research Article Open access 13 February 2020 Pages: 511 - 517

    

13. Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US

    • Steve Edelman
    • Fang Liz Zhou
    • Vijay N. Joish

    Original Research Article Open access 29 January 2020 Pages: 519 - 528

    

14. HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?

    • Mikyung Kelly Seo
    • Oddbjørn Straume
    • John Cairns

    Original Research Article Open access 27 January 2020 Pages: 529 - 539

    

15. Metabolic Acidosis in Preterm Infants is Associated with a Longer Length of Stay in the Neonatal Intensive Care Unit

    • Marika Paul
    • Jamie Partridge
    • Richard J. Schanler

    Original Research Article Open access 23 January 2020 Pages: 541 - 547

    

16. Comment on: “Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights”

    • Omar Salamanca

    Letter to the Editor Open access 13 July 2020 Pages: 549 - 550

17. Authors’ Reply to Salamanca: “Systematic Review of Economic Evaluations in Primary Open Angle Glaucoma: Decision Analytic Modeling Insights”

    • Jose Bartelt-Hofer
    • Steffen Flessa

    Letter to the Editor Open access 13 July 2020 Pages: 551 - 552

18. Correction to: Benefit–Cost Analysis of the Danish Sun Safety Campaign 2007–2015: Cost Savings from Sunburn and Sunbed Use Reduction and Derived Skin Cancer Reductions 2007–2040 in the Danish Population

    • Brian Køster
    • Maria K. H. Meyer
    • Peter Dalum

    Correction Open access 05 November 2019 Pages: 553 - 554